These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
274 related items for PubMed ID: 27849354
1. The treatment effects of flaxseed-derived secoisolariciresinol diglycoside and its metabolite enterolactone on benign prostatic hyperplasia involve the G protein-coupled estrogen receptor 1. Ren GY, Chen CY, Chen WG, Huang Y, Qin LQ, Chen LH. Appl Physiol Nutr Metab; 2016 Dec; 41(12):1303-1310. PubMed ID: 27849354 [Abstract] [Full Text] [Related]
2. Preventive effects of lignan extract from flax hulls on experimentally induced benign prostate hyperplasia. Bisson JF, Hidalgo S, Simons R, Verbruggen M. J Med Food; 2014 Jun; 17(6):650-6. PubMed ID: 24460407 [Abstract] [Full Text] [Related]
3. Comparative pharmacokinetics of purified flaxseed and associated mammalian lignans in male Wistar rats. Mukker JK, Singh RS, Muir AD, Krol ES, Alcorn J. Br J Nutr; 2015 Mar 14; 113(5):749-57. PubMed ID: 25716060 [Abstract] [Full Text] [Related]
4. The flaxseed lignan secoisolariciresinol diglucoside decreases local inflammation, suppresses NFκB signaling, and inhibits mammary tumor growth. Bowers LW, Lineberger CG, Ford NA, Rossi EL, Punjala A, Camp KK, Kimler BK, Fabian CJ, Hursting SD. Breast Cancer Res Treat; 2019 Feb 14; 173(3):545-557. PubMed ID: 30367332 [Abstract] [Full Text] [Related]
5. The anti-cancer effect of flaxseed lignan derivatives on different acute myeloid leukemia cancer cells. Tannous S, Haykal T, Dhaini J, Hodroj MH, Rizk S. Biomed Pharmacother; 2020 Dec 14; 132():110884. PubMed ID: 33080470 [Abstract] [Full Text] [Related]
6. Metabolism of secoisolariciresinol-diglycoside the dietary precursor to the intestinally derived lignan enterolactone in humans. Setchell KD, Brown NM, Zimmer-Nechemias L, Wolfe B, Jha P, Heubi JE. Food Funct; 2014 Mar 14; 5(3):491-501. PubMed ID: 24429845 [Abstract] [Full Text] [Related]
9. Bioaccessibility of lignans from flaxseed (Linum usitatissimum L.) determined by single-batch in vitro simulation of the digestive process. Fuentealba C, Figuerola F, Estévez AM, Bastías JM, Muñoz O. J Sci Food Agric; 2014 Jul 14; 94(9):1729-38. PubMed ID: 24243589 [Abstract] [Full Text] [Related]
10. Dose-dependent production of mammalian lignans in rats and in vitro from the purified precursor secoisolariciresinol diglycoside in flaxseed. Rickard SE, Orcheson LJ, Seidl MM, Luyengi L, Fong HH, Thompson LU. J Nutr; 1996 Aug 14; 126(8):2012-9. PubMed ID: 8759374 [Abstract] [Full Text] [Related]
11. Dietary flaxseed lignan or oil combined with tamoxifen treatment affects MCF-7 tumor growth through estrogen receptor- and growth factor-signaling pathways. Saggar JK, Chen J, Corey P, Thompson LU. Mol Nutr Food Res; 2010 Mar 14; 54(3):415-25. PubMed ID: 19904759 [Abstract] [Full Text] [Related]
16. Human intestinal bacteria capable of transforming secoisolariciresinol diglucoside to mammalian lignans, enterodiol and enterolactone. Wang LQ, Meselhy MR, Li Y, Qin GW, Hattori M. Chem Pharm Bull (Tokyo); 2000 Nov 14; 48(11):1606-10. PubMed ID: 11086885 [Abstract] [Full Text] [Related]
17. Health effects with consumption of the flax lignan secoisolariciresinol diglucoside. Adolphe JL, Whiting SJ, Juurlink BH, Thorpe LU, Alcorn J. Br J Nutr; 2010 Apr 14; 103(7):929-38. PubMed ID: 20003621 [Abstract] [Full Text] [Related]